Free Trial

Oncology Institute (TOI) Short Interest Ratio & Short Volume

$0.49
+0.02 (+4.22%)
(As of 05/31/2024 ET)

Oncology Institute Short Interest Data

Current Short Interest
217,600 shares
Previous Short Interest
268,400 shares
Change Vs. Previous Month
-18.93%
Dollar Volume Sold Short
$148,838.40
Short Interest Ratio
1.3 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
74,440,000 shares
Float Size
32,650,000 shares
Short Percent of Float
0.67%
Today's Trading Volume
109,236 shares
Average Trading Volume
159,386 shares
Today's Volume Vs. Average
69%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Oncology Institute ?

Sign up to receive the latest short interest report for Oncology Institute and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TOI Short Interest Over Time

TOI Days to Cover Over Time

TOI Percentage of Float Shorted Over Time

Oncology Institute Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024217,600 shares $148,838.40 -18.9%0.7%1.3 $0.68
4/30/2024268,400 shares $284,504.00 +6.5%0.9%2.2 $1.06
4/15/2024252,000 shares $299,880.00 -4.1%0.8%2.2 $1.19
3/31/2024262,700 shares $415,066.00 +12.1%0.8%2.1 $1.58
3/15/2024234,300 shares $393,624.00 +3.8%0.8%1.7 $1.68
2/29/2024225,700 shares $424,316.00 -7.0%0.7%1.2 $1.88
2/15/2024242,600 shares $434,254.00 -20.8%0.8%1.1 $1.79
1/31/2024306,200 shares $627,710.00 -7.5%1.0%1.1 $2.05
1/15/2024330,900 shares $684,963.00 +20.3%0.8%1.1 $2.07
12/31/2023275,000 shares $561,000.00 +51.3%0.7%0.9 $2.04
12/15/2023181,800 shares $245,430.00 -35.0%0.7%0.6 $1.35
11/30/2023279,800 shares $478,458.00 -37.4%1.1%1 $1.71
11/15/2023447,000 shares $992,340.00 +91.3%1.7%1.8 $2.22
10/31/2023233,700 shares $446,367.00 -4.6%0.9%1 $1.91
10/15/2023245,000 shares $379,750.00 -8.8%0.9%1.2 $1.55
9/30/2023268,500 shares $375,900.00 +6.2%1.0%1 $1.40
9/15/2023252,900 shares $417,285.00 -11.9%1.0%0.9 $1.65
8/31/2023286,900 shares $332,804.00 -17.9%0.9%0.4 $1.16
8/15/2023349,300 shares $299,629.54 +42.0%1.1%0.4 $0.86
7/31/2023246,000 shares $240,440.40 -45.3%0.8%0.3 $0.98
7/15/2023450,000 shares $319,635.00 -7.3%1.4%0.5 $0.71
6/30/2023485,400 shares $267,067.08 -74.3%1.5%0.6 $0.55
6/15/20231,890,000 shares $1.14 million +39.0%6.0%2.4 $0.61
5/31/20231,360,000 shares $581,400.00 +5.4%4.4%2.1 $0.43
5/15/20231,290,000 shares $580,500.00 +1.6%4.1%6.6 $0.45
4/30/20231,270,000 shares $647,700.00 +5.8%4.1%7.4 $0.51
4/15/20231,200,000 shares $716,760.00 +2.6%3.9%6.9 $0.60
3/31/20231,170,000 shares $793,143.00 +13.6%3.8%7.2 $0.68
3/15/20231,030,000 shares $682,066.00 +12.0%3.5%5.7 $0.66
2/28/2023919,300 shares $1.30 million -21.4%3.2%6.7 $1.41
2/15/20231,170,000 shares $1.83 million -14.6%4.0%6.9 $1.56
1/31/20231,370,000 shares $2.03 million +31.7%4.7%7.1 $1.48
1/15/20231,040,000 shares $1.77 million +4.0%3.6%5.2 $1.70
12/30/20221,000,000 shares $1.65 million -8.3%3.8%5.1 $1.65
12/15/20221,090,000 shares $1.00 million +39.6%4.2%5.6 $0.92
11/30/2022780,600 shares $1.10 million -17.0%3.0%3.9 $1.41
11/15/2022940,500 shares $1.92 million -3.4%3.6%5.6 $2.04
10/31/2022973,100 shares $4.42 million -8.2%3.7%7 $4.54
10/15/20221,060,000 shares $4.71 million -18.5%4.1%8.4 $4.44
9/30/20221,300,000 shares $6.02 million +46.7%5.1%10.8 $4.63
This TSLA short trade is on a nine win hot streak (Ad)

Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.

But I can promise that you’ll see all the details for yourself here.
9/15/2022886,100 shares $4.08 million -6.6%3.5%6 $4.61
8/31/2022948,900 shares $6.03 million +0.0%3.7%7.8 $6.35
8/15/2022948,700 shares $5.87 million +8.1%3.8%7.5 $6.19
7/31/2022878,000 shares $5.67 million -4.3%3.5%6.8 $6.46
7/15/2022917,000 shares $5.36 million +15.0%3.6%6.7 $5.84
6/30/2022797,600 shares $4.04 million +83.2%3.1%5.7 $5.06
6/15/2022435,400 shares $2.79 million -24.7%1.7%3.1 $6.40
5/31/2022578,100 shares $5.21 million +5.2%2.3%5.6 $9.01
5/15/2022549,300 shares $3.36 million -8.6%2.2%4.7 $6.12
4/30/2022600,800 shares $4.72 million +5.0%2.5%5.8 $7.86
4/15/2022572,000 shares $3.95 million +3.2%2.4%6.1 $6.90
3/31/2022554,100 shares $3.95 million +9.0%2.2%5.8 $7.13
3/15/2022508,500 shares $3.48 million -21.6%2.0%4.3 $6.84
2/28/2022648,800 shares $3.48 million +4.9%2.5%5.2 $5.37
2/15/2022618,500 shares $3.90 million 0.0%2.4%4.8 $6.31
1/31/2022618,700 shares $4.00 million +2.3%2.4%4.5 $6.46
1/15/2022605,100 shares $4.74 million +8.7%2.3%3.8 $7.83
12/31/2021556,500 shares $5.43 million No Change2.2%3.6 $9.75

TOI Short Interest - Frequently Asked Questions

What is Oncology Institute's current short interest?

Short interest is the volume of Oncology Institute shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 217,600 shares of TOI short. 0.67% of Oncology Institute's shares are currently sold short. Learn More on Oncology Institute's current short interest.

What is a good short interest ratio for Oncology Institute?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TOI shares currently have a short interest ratio of 1.0. Learn More on Oncology Institute's short interest ratio.

What is a good short interest percentage for Oncology Institute?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.67% of Oncology Institute's floating shares are currently sold short.

Is Oncology Institute's short interest increasing or decreasing?

Oncology Institute saw a decline in short interest in May. As of May 15th, there was short interest totaling 217,600 shares, a decline of 18.9% from the previous total of 268,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Oncology Institute's float size?

Oncology Institute currently has issued a total of 74,440,000 shares. Some of Oncology Institute's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncology Institute currently has a public float of 32,650,000 shares.

How does Oncology Institute's short interest compare to its competitors?

0.67% of Oncology Institute's shares are currently sold short. Here is how the short interest of companies compare to Oncology Institute: SHL Telemedicine Ltd. (0.00%), Pono Capital Two, Inc. (4.19%), Concord Medical Services Holdings Limited (0.01%), Hims & Hers Health, Inc. (14.69%), Teladoc Health, Inc. (15.94%), LifeMD, Inc. (8.39%), AirSculpt Technologies, Inc. (14.99%), Quipt Home Medical Corp. (1.62%), RAPT Therapeutics, Inc. (8.91%), FitLife Brands, Inc. (0.08%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Oncology Institute stock?

Short selling TOI is an investing strategy that aims to generate trading profit from Oncology Institute as its price is falling. TOI shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oncology Institute?

A short squeeze for Oncology Institute occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TOI, which in turn drives the price of the stock up even further.

How often is Oncology Institute's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOI, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:TOI) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners